Assaf Shelef
Overview
Explore the profile of Assaf Shelef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raad R, Hirschmann S, Bloemhof-Bris E, Weizman S, Porat D, Sinai O, et al.
BMC Psychiatry
. 2024 Nov;
24(1):801.
PMID: 39543500
Violence risk is a major challenge among acute psychiatric inpatients. The study aimed to predict violent behavior risk in an acute psychiatric ward using video recordings from the emergency department....
2.
Dahan S, Bloemhof-Bris E, Segev R, Abramovich M, Levy G, Shelef A
Stress Health
. 2024 Aug;
40(5):e3459.
PMID: 39106087
The ongoing Israel-Hamas war is posing additional challenges for mental health workers in an already stressful workplace. This study centres on the psychological effects of the shared traumatic reality on...
3.
Bloemhof-Bris E, Meiri D, Sulimani L, Genesh S, Wexler G, Cohen I, et al.
Psychiatry Res
. 2024 May;
337:115967.
PMID: 38796933
The role of the endocannabinoid system (ECS) in depression and suicidality has recently emerged. The purpose of the study was to identify changes in plasma endocannabinoid concentrations of several endocannabinoids...
4.
Dvorak L, Bloemhof-Bris E, Shelef A, Halperin D, Wexler G, Talmon O, et al.
J Psychiatr Res
. 2024 Apr;
174:66-72.
PMID: 38626563
One in five people will likely suffer from major depressive disorder (MDD) during their life. Thirty percent of those with MDD will experience Treatment Resistant Depression (TRD), which is characterized...
5.
Shelef A, Alaa H, Bloemhof-Bris E, Halperin D, Weizman S, Stryjer R
Front Psychiatry
. 2024 Mar;
15:1293676.
PMID: 38487572
Introduction: Chloral hydrate (CH), a medication dating back to 1832, is tranquilizer and sleep promoter still used today. It remains an option for short-term insomnia therapy and sedation before medical...
6.
Neupane S, Daray F, Ballard E, Galfalvy H, Itzhaky L, Segev A, et al.
Eur Neuropsychopharmacol
. 2023 Jun;
75:15-30.
PMID: 37356288
Biomarkers that can differentiate between psychiatric disorders with and without suicidal behavior history from each other and from healthy volunteers may explain part of the pathogenesis of suicidal behavior. We...
7.
Fridman J, Bloemhof-Bris E, Weizman S, Kessler T, Porat D, Ivry A, et al.
Clin Neuropharmacol
. 2023 Jun;
PMID: 37335845
Objectives: The mechanism of inflammation of the immune system, for example, such circulatory markers as the neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume (MPV), has been shown in many studies...
8.
Dahan S, Bloemhof-Bris E, Weizman S, Pesah M, Gorno N, Abu Shah M, et al.
J Eval Clin Pract
. 2022 Jun;
28(6):948-957.
PMID: 35731528
Rationale And Objective: At the beginning of vaccination against coronavirus disease 2019 (COVID-19), information about the effects of the vaccine was not known and hesitancy was observed among the population....
9.
Shelef A, Dahan S, Weizman S, Bloemhof Bris E
Isr Med Assoc J
. 2022 Feb;
24(2):74-77.
PMID: 35187893
Background: Risk factors for severe coronavirus disease-2019 (COVID-19) infection include old age, chronic illness, and neurological conditions. In contrast, high vitamin D levels are known to augment immune activity and...
10.
Sinai O, Stryjer R, Bloemhof-Bris E, Weizman S, Shelef A
Int Clin Psychopharmacol
. 2021 Nov;
37(1):9-13.
PMID: 34825897
Many psychotic patients are treated with antipsychotic medications during acute agitation and aggressive behavior episodes in an attempt to achieve a rapid calming effect. Those medications include olanzapine, zuclopenthixol acetate,...